Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Ertugliflozin in Chronic Heart Failure
- Status
- RECRUITING
- Phase
- PHASE2
Spondyloarthritis: Inducing Drug-free Remission by Early TNF-alpha Blockade
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
AN0025 and Pembrolizumab Combination in Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Cisplatin+Pembrolizumab+RT in Vulvar Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE3
Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)
- Status
- COMPLETED
- Phase
- PHASE2
Frespaciguat (MK-5475) in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009)
- Status
- WITHDRAWN
- Phase
- PHASE1
Nexplanon Use in Women Primarily Choosing a Combined Oral Contraceptive
- Status
- COMPLETED
- Phase
- PHASE4
Pembrolizumab, Ibrutinib and Rituximab in PCNSL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Olaparib Monotherapy and Olaparib + Pembrolizumab Combination Therapy for Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID)
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901
- Status
- UNKNOWN
- Phase
- PHASE2
Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-033)
- Status
- COMPLETED
- Phase
- PHASE3